Pfizer may partner with Yale

November 18, 2002 • 0
Pfizer, the world’s largest drug company, is close to announcing plans for construction of a new inpatient clinical trial center in conjunction with Yale University and the city of New Haven, a company spokesman said. The proposed center would be used for phase-I clinical drug trials, the first stage of government-mandated tests that must be »

Yale research team offers SIDS explanation

May 1, 2002 • 0
A Yale School of Medicine research team may have found an answer to why one out of every 1,000 babies in the industrial world dies from sudden infant death syndrome. The team, which included senior investigator Dr. George Richerson, associate professor of neurology and physiology, clarified how specific neurons in the brain might play a »

Biomedical Engineering gets NIH grant

April 25, 2002 • 1
Yale’s Biomedical Engineering Program will receive a $7.1 million grant — the largest in its history — for a project designed to study epileptic seizures, the University will announce today. The grant will be the very first given out by the National Institute of Biomedical Imaging and Bioengineering, the newest institute at the National Institutes »

Professor touts biomedical engineering gadgets

April 17, 2002 • 0
Imagine a microchip implant that could act like a miniature pharmacy inside your body, releasing medicines when it deemed necessary. Professor Robert Langer of the Massachusetts Institute of Technology claims this could be part of the future of drug delivery. Speaking to a capacity crowd in Davies Auditorium on Tuesday, the acclaimed chemical and biomedical »

Med school building on target

April 10, 2002 • 1
Staff Reporters More than two years ago, Yale announced it was planning to invest $500 million in Yale School of Medicine facilities over the next decade. With the completion of the $176.6 million Congress Avenue facility scheduled for November, the investment will soon start to pay tangible dividends. The facility, which will have six new »

State biosciences industry prospering

March 28, 2002 • 0
Despite tough economic times nationally, Connecticut’s biosciences industry is doing well, according to a new statewide economic report. At a conference Monday, Connecticut United for Research Excellence, a non-profit corporation, presented its Seventh Annual Economic Report, which touts dozens of economic signals indicating that the state’s BioScience Cluster continues to grow and prosper economically. The »

Walking, the next generation

March 6, 2002 • 0
Engineer John Morrell ’86 didn’t give the opening remarks for his talk in Davies Auditorium from the normal podium — he delivered them while cruising around the front of the room on what appeared to be a glorified motorized scooter. In the second of three engineering lectures held this spring in honor of the Faculty »

2 engineering professors win high honors

February 22, 2002 • 0
By the end of 1994, the papers and books of engineering professor Thomas Graedel, a specialist in industrial ecology, had been cited more than 2,200 times, placing his citation record among the top 1 percent of all active scientists. Thus it was hardly surprising when the National Academy of Engineers elected Graedel and fellow Yale »

Prof brings physics to life in talk

February 13, 2002 • 0
In the fifth century B.C., Democritus developed the theory that objects were made up of atoms. In the 21st century, Yale applied physics professor Michel Devoret hopes do something as novel — take quantum mechanics and build computers with it. In a lecture Tuesday that included not one mathematical formula, Devoret described the world of »

Researcher models black hole collision

February 11, 2002 • 0
The merging of two black holes is one of the strangest occurrences expected in modern astronomy. But now Yale researcher Priyamvada Natarajan, an assistant astronomy professor, is helping to solve the mystery behind the merging of these galactic phenomena. Natarajan found that these mergers complete themselves with a massive release of energy, possibly powering the »

Researcher working on cocaine vaccine

January 31, 2002 • 0
In the growing market of pharmacological drug development, a new cocaine vaccine may be another success story for a clinical researcher at Yale. Dr. Thomas Kosten, a professor of psychiatry at the School of Medicine, led a recent research project aimed at finding a treatment for the estimated three million cocaine abusers in the United »

AIDS center expands its reach to work overseas

January 23, 2002 • 0
Facing the ever-growing AIDS pandemic, Yale set out five years ago to create a center to coordinate and facilitate HIV research at home and abroad. In the last month, this project, the Yale Center for Interdisciplinary Research on AIDS, or CIRA, received over $12 million in the form of two grants to further expand its »